SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Quarterly Results - Marksans Pharma

Marksans Pharma

BSE: 524404|NSE: MARKSANS|ISIN: INE750C01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 29, 16:01
45.75
-0.1 (-0.22%)
VOLUME 363,873
LIVE
NSE
Apr 29, 16:01
45.85
0.05 (0.11%)
VOLUME 1,718,923
Download Annual Report PDF Format 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Quarterly Results of Marksans Pharma

------------------- in Rs. Cr. -------------------
Dec '15 Sep '15 Jun '15 Mar '15 Dec '14
Net Sales/Income from operations 69.30 117.08 102.32 91.74 105.64
Other Operating Income -- -- 2.30 3.09 --
Total Income From Operations 69.30 117.08 104.62 94.83 105.64
EXPENDITURE
Consumption of Raw Materials 23.74 50.09 44.76 49.61 52.43
Purchase of Traded Goods 3.00 5.26 5.97 3.22 4.87
Increase/Decrease in Stocks 1.99 3.03 -1.77 -1.36 -5.63
Power & Fuel -- -- -- -- --
Employees Cost 6.38 5.51 5.31 7.06 5.32
Depreciation 4.03 3.67 2.66 2.41 2.22
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- -- -- -- --
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 15.40 12.19 11.19 15.49 13.02
P/L Before Other Inc. , Int., Excpt. Items & Tax 14.75 37.34 36.51 18.39 33.42
Other Income -- -- -- -- --
P/L Before Int., Excpt. Items & Tax 14.75 37.34 36.51 18.39 33.42
Interest 1.40 1.60 2.38 1.50 5.33
P/L Before Exceptional Items & Tax 13.35 35.74 34.13 16.89 28.09
Exceptional Items -- -- -- -- --
P/L Before Tax 13.35 35.74 34.13 16.89 28.09
Tax -0.64 7.20 10.25 4.59 11.57
P/L After Tax from Ordinary Activities 13.99 28.54 23.88 12.31 16.52
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 13.99 28.54 23.88 12.31 16.52
Equity Share Capital 40.93 40.93 40.93 40.93 38.53
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 0.34 0.70 0.58 0.30 0.43
Diluted EPS 0.34 0.70 0.58 0.30 0.43
EPS After Extra Ordinary
Basic EPS 0.34 0.70 0.58 0.30 0.43
Diluted EPS 0.34 0.70 0.58 0.30 0.43
Public Share Holding
No Of Shares (Crores) -- 21.18 21.18 21.18 18.78
Share Holding (%) -- 51.75 51.75 51.75 48.74
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- 19.75 19.75 19.75 19.75
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- 100.00 100.00 100.00 100.00
- Per. of shares (as a % of the total Share Cap. of the company) -- 48.25 48.25 48.25 51.26
Notes
Source : Dion Global Solutions Limited
Quick Links for marksanspharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.